What Is a UVJ Stone and How Is It Treated?

A UVJ stone is a kidney stone that has traveled down the ureter and become lodged at the ureterovesical junction, the point where the ureter meets the bladder. This is the narrowest segment of the entire urinary tract, and it is the single most common spot for a stone to get stuck. In one study of patients evaluated for suspected ureteral stones, stones were found at the UVJ in about 47% of cases, more than any other location along the ureter.¹ Treatment depends mostly on the stone’s size, but the location itself carries some advantages when it comes to passing the stone naturally or removing it.

Why Stones Get Stuck at the UVJ

Kidney stones form in the kidney and often cause no symptoms there. The trouble starts when a stone drops into the ureter, the thin tube that carries urine from each kidney to the bladder. The ureter has three natural pinch points where it narrows, and the UVJ is the tightest of them. At this junction, the ureter tunnels through the muscular wall of the bladder at an oblique angle, creating a valve-like mechanism that prevents urine from flowing backward. That same anatomy makes it a bottleneck for stones. A stone that sailed through the wider sections of the ureter can grind to a halt at this final squeeze.

The silver lining is that if a stone has already made it to the UVJ, it has passed through most of the ureter. It is just centimeters from the bladder. That proximity makes spontaneous passage more likely compared to stones stuck higher up, and it also means certain surgical approaches are more straightforward.

What It Feels Like

The classic symptom of a UVJ stone is sudden, intense pain in the lower abdomen or groin. Unlike stones lodged higher in the ureter, which tend to cause flank pain that radiates toward the back, UVJ stones often produce pain that is felt lower, sometimes mimicking pelvic or bladder problems. You might also experience a frequent, urgent need to urinate, burning with urination, or blood in the urine. These urinary symptoms happen because the stone sits right at the bladder wall, irritating it directly.

The pain can be severe enough to send people to the emergency department, and the location of symptoms occasionally leads to diagnostic confusion. A case report documented a teenage male whose UVJ stone symptoms were initially mistaken for appendicitis. Ultrasound at the bedside revealed that the suspected appendix was actually a dilated ureter with a stone inside it.² In women, UVJ stone pain can also mimic gynecological conditions. The overlap with other causes of lower abdominal pain is one reason imaging is usually needed to confirm the diagnosis.

One detail that surprises many people: not every ureteral stone causes visible swelling of the kidney. While roughly nine out of ten patients with ureteral stones showed some degree of kidney swelling on imaging in one study, about 11% had none at all.¹ A UVJ stone can cause significant pain even without a dramatic backup of urine in the kidney, so a normal-looking kidney on ultrasound does not rule out a stone.

How UVJ Stones Are Diagnosed

A CT scan without contrast is the gold standard for finding ureteral stones. It picks up stones of virtually any size and composition, identifies their exact location, and shows whether urine is backing up into the kidney. In one comparative study, CT detected ureteral stones in about 97% of cases, while ultrasound caught roughly 81%.³ A systematic review of 12 studies confirmed that CT is the most accurate option, though ultrasound remains a reasonable alternative, particularly when radiation exposure is a concern.⁴

Ultrasound’s main weakness is its lower sensitivity. It can miss smaller stones and is less reliable at pinpointing a stone’s exact position along the ureter, especially in the middle segment. But for UVJ stones specifically, ultrasound has some advantages: the bladder serves as an acoustic window, making the junction easier to visualize than higher parts of the ureter. There were no significant differences in ultrasound performance based on stone location in a separate surveillance study, though CT still outperformed it overall.⁵ For most non-pregnant adults presenting with acute pain suggestive of a stone, CT is the first-choice imaging study.

When You Can Wait It Out

Small UVJ stones often pass on their own, and the closer a stone sits to the bladder, the better its odds. Size is the single biggest factor determining whether a stone will pass without intervention. A large study tracking nearly 400 stones found that those 3 mm or smaller passed spontaneously about 98% of the time. At 4 mm, the rate was around 81%. At 5 mm it dropped to 65%, and at 6 mm only about a third passed on their own.⁶ Another study found broadly consistent results with somewhat lower rates overall, reporting passage of 76% for stones 2 to 4 mm and 60% for stones 5 to 7 mm.⁷

Conservative management means giving the stone time to pass while managing pain. Doctors typically recommend plenty of fluids, pain relievers, and sometimes a medication called an alpha-blocker. These drugs relax the smooth muscle in the lower ureter and the UVJ, theoretically widening the passage. Tamsulosin is the most commonly prescribed alpha-blocker for this purpose, and the evidence supports its use for distal ureteral and UVJ stones. A meta-analysis of randomized trials found that tamsulosin was linked to a roughly 44% higher stone expulsion rate compared to placebo or standard care, along with shorter time to passage and fewer episodes of painful colic.⁸

In a smaller trial focused specifically on distal ureteral stones, the group receiving tamsulosin passed their stones about 90% of the time, compared with about 71% in the control group. The tamsulosin group also needed fewer painkillers and passed their stones several days sooner on average.⁹ Another alpha-blocker, silodosin, has also been studied for this use. In one head-to-head comparison, tamsulosin and silodosin performed similarly, with no clear winner. The strongest predictor of whether a stone would pass was not which drug the patient took but how close the stone sat to the UVJ at the start of treatment.¹⁰

There is also emerging research on the thickness of the ureteral wall at the UVJ as a predictor of whether medical therapy will succeed. One study found that ureteral wall thickness above roughly 3.7 mm was associated with lower odds of the stone passing with medication alone, and that wall thickness along with stone size were the two independent factors influencing treatment outcomes.¹¹ That kind of detail could eventually help doctors decide earlier whether to keep waiting or move to intervention, but for now it remains more of a research finding than a routine clinical measurement.

When Surgery Is Needed

If a stone does not pass within a few weeks, if it is too large to pass on its own, or if complications develop (uncontrollable pain, infection, kidney damage from obstruction), the stone needs to be removed. The two main procedures are ureteroscopy and shockwave lithotripsy.

Ureteroscopy involves threading a thin, flexible or semi-rigid scope up through the urethra and bladder into the ureter, directly visualizing the stone, and breaking it apart with a laser fiber. The fragments are either flushed out or pulled out with a tiny basket. For UVJ stones, the approach is especially convenient because the stone is right at the bladder entrance, so the scope does not have to travel far.

Shockwave lithotripsy, or SWL, takes a different approach. It uses focused sound waves delivered from outside the body to break the stone into smaller pieces that can then pass naturally. It is noninvasive and usually does not require general anesthesia, making it appealing to patients. However, for ureteral stones overall, ureteroscopy tends to produce better results. A large randomized trial comparing the two found that about 22% of patients who had SWL required additional treatment afterward, compared with about 10% in the ureteroscopy group.¹² For stones at the UVJ specifically, SWL can be less effective because pelvic bones can interfere with wave delivery, which is why ureteroscopy is generally preferred at this location.

After ureteroscopy, doctors often place a temporary ureteral stent, a thin tube that runs from the kidney to the bladder to keep the ureter open while it heals. Stents are effective at preventing swelling from blocking urine flow, but they are not comfortable. Patients with stents frequently report pain, urinary urgency, and a feeling of incomplete emptying. One study that tracked daily symptoms after ureteroscopy found that pain and urinary symptoms spiked in the first two days after surgery, stayed elevated for the entire time the stent was in place, and varied widely from person to person.¹³ Stents are typically removed within a week or two, and most patients feel much better once the stent comes out.

Newer Laser Technology

The laser used during ureteroscopy has evolved. For years, the standard tool has been the holmium laser, which breaks stones into fragments. A newer option, the thulium fiber laser, is increasingly available and appears to offer some advantages. A meta-analysis found that the thulium fiber laser was associated with higher stone-free rates, shorter operating times, and significantly less stone migration (the problem of stone fragments bouncing up into the kidney during treatment).¹⁴ A prospective single-center study found comparable surgical times between the two lasers but confirmed that the thulium fiber laser produced better endoscopic visibility and less stone retropulsion.¹⁵

Not every study shows the thulium fiber laser pulling ahead on all metrics. A prospective trial comparing the two found similar stone-free rates (about 72% for the thulium laser versus 68% for the holmium laser), though the thulium group had significantly less bleeding during the procedure.¹⁶ The thulium fiber laser’s thinner fiber also makes it easier to use with flexible scopes, which matters more for stones in the kidney than at the UVJ. Either way, both lasers are effective for UVJ stones; the technology is improving but the choice between them is not yet a make-or-break factor for patients.

Infected and Obstructed Stones

A UVJ stone that causes a complete blockage and a concurrent urinary tract infection is one of the few true urological emergencies. Infected urine trapped behind a stone can escalate to sepsis quickly. The immediate priority is not to remove the stone but to drain the kidney. This is done either by placing a ureteral stent from below (through the bladder) or by placing a nephrostomy tube through the skin of the back directly into the kidney. The stone removal comes later, once the infection is controlled.

A systematic review and meta-analysis comparing these two drainage methods found no significant differences in how quickly fever resolved, how fast white blood cell counts normalized, how long patients stayed in the hospital, or procedure success rates.¹⁷ In practice, the choice between the two often comes down to anatomy, the surgeon’s experience, and whether a stent can be passed around the stone. The critical thing is to get drainage established quickly. Definitive stone removal waits until antibiotics have cleared the infection.

UVJ Stones During Pregnancy

Pregnancy complicates stone management in several ways. The ureter naturally dilates during pregnancy due to hormonal changes and the growing uterus pressing against it, which can mask the imaging signs of obstruction and make diagnosis harder. Ultrasound is the first imaging choice because it uses no radiation, but it has an even harder time distinguishing stone-related blockage from the normal dilation of pregnancy.¹⁸ When ultrasound is inconclusive, MRI without contrast is preferred as a second-line test, and low-dose CT is reserved as a last resort.

The initial approach for a symptomatic stone in a pregnant patient is conservative: pain control with pregnancy-safe medications, hydration, and watchful waiting. Most stones will pass on their own. For those that do not, temporary stent placement can relieve obstruction until the pregnancy progresses to a point where more definitive treatment is safer, or until delivery. Management requires a multidisciplinary approach involving both urologists and obstetricians, with treatment decisions individualized based on how far along the pregnancy is, how severe symptoms are, and whether complications like infection develop.¹⁹

Preventing the Next Stone

About half of people who form a kidney stone will form another one within ten years if they do not change anything. That recurrence rate makes prevention a practical concern, not just a theoretical one. The composition of the stone matters for targeted prevention: calcium oxalate stones, uric acid stones, and mixed stones each have different metabolic profiles, and patients who form mixed stones show overlapping abnormalities that need to be addressed from multiple angles.²⁰ If you have had a stone removed or passed one, saving it for composition analysis can guide specific prevention strategies.

The clearest evidence for prevention is simple: drink more water. A systematic review and meta-analysis of randomized trials concluded that high water intake reduces the risk of recurrent stones, with one meta-analysis finding a meaningful reduction in recurrence (about 61% lower risk) in patients who increased their fluid intake.²¹ The goal is usually to produce more than two liters of urine per day, which for most people means drinking enough that their urine stays pale yellow.

Dietary modifications have a less dramatic evidence base. One well-known trial found that a diet with normal calcium, low protein, and low salt cut recurrence roughly in half compared to a low-calcium diet alone. But when other dietary approaches like low protein with high fiber were pooled together in a meta-analysis, the overall effect on recurrence was not statistically significant.²¹ A separate systematic review noted that reducing soft-drink intake may help prevent painful episodes in men who drink a lot of soda, and that getting adequate dietary calcium (from food, not supplements) likely offers some protection.²² The counterintuitive takeaway is that restricting calcium in your diet can actually increase your risk of calcium stones, because dietary calcium binds to oxalate in the gut and prevents it from being absorbed and excreted into the urine.

The Emergency Department Burden

Kidney and ureteral stones account for a large volume of emergency department visits, and a meaningful fraction of those visits could potentially be managed outside the ED. An analysis of over 167,000 ED encounters for stone disease found that about 8% were classified as potentially avoidable, representing roughly $95 million per year in costs.²³ Individual avoidable visits were far cheaper (about $2,100 on average) than unavoidable ones (about $5,900), but when looking at total episode-based costs including follow-up care, the two groups cost about the same. This suggests that keeping some stone patients out of the ED with better outpatient pain management and faster urology follow-up would save money at the visit level without changing the overall cost of treating the stone. For patients, it also means less time sitting in an overcrowded waiting room in agony. If you have a known history of stones and develop symptoms consistent with a small, uncomplicated stone, having a conversation with your urologist about a management plan before the next episode can sometimes spare you an unnecessary ED trip.